These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30034611)

  • 41. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
    Sharma K; Tanwar O; Deora GS; Ali S; Alam MM; Zaman MS; Krishna VS; Sriram D; Akhter M
    Bioorg Med Chem; 2019 Apr; 27(7):1421-1429. PubMed ID: 30827867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and evaluation of novel diphenyl ether derivatives against drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Kar SS; Bhat VG; Shenoy VP; Bairy I; Shenoy GG
    Chem Biol Drug Des; 2019 Jan; 93(1):60-66. PubMed ID: 30118192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
    Narayanaswamy VK; Nayak SK; Pillay M; Prasanna R; Coovadia YM; Odhav B
    Chem Biol Drug Des; 2013 Feb; 81(2):219-27. PubMed ID: 23150983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
    Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions.
    Zhang NN; Tang YX; Qian L; Gao YM; Liu ZY; Zou ZL; Zhang TY; Yan M
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800277. PubMed ID: 30698293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
    Patel H; Jadhav H; Ansari I; Pawara R; Surana S
    Eur J Med Chem; 2019 Apr; 167():1-9. PubMed ID: 30743094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Feb; 164():665-677. PubMed ID: 30654238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis.
    Hussain A; Rather MA; Bhat ZS; Majeed A; Maqbool M; Shah AM; Aga MA; Shah A; Mushtaq S; Sangwan PL; Hassan QP; Ahmad Z
    Int J Antimicrob Agents; 2019 Jan; 53(1):49-53. PubMed ID: 30267759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ring-substituted quinolines as potential anti-tuberculosis agents.
    Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
    Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols.
    Bisht SS; Dwivedi N; Chaturvedi V; Anand N; Misra M; Sharma R; Kumar B; Dwivedi R; Singh S; Sinha SK; Gupta V; Mishra PR; Dwivedi AK; Tripathi RP
    Eur J Med Chem; 2010 Dec; 45(12):5965-78. PubMed ID: 20970222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents.
    Tseng CH; Tung CW; Wu CH; Tzeng CC; Chen YH; Hwang TL; Chen YL
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28621733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
    Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
    Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.